Annals of Hepato-Biliary-Pancreatic Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5859   pISSN 2508-5778

Table. 3.

Table. 3.

(A) Comparison of complication by Clavien-Dindo classification between normal and persistently lymphopenic patients. (B) Comparison of adverse events between normal and persistently lymphopenic patients

Overall No lymphopenia n=80 (%) Persistent lymphopenia n=81 (%) p value
(A) Complication
None 54 31 (38.8) 23 (28.4) 0.160
No intervention required
Class 1 33 21 (26.3) 12 (14.8) 0.078
Intervention required <0.001
Class 2 40 16 (20) 24 (29.6)
Class 3 19 9 (11.3) 10 (12.3)
Class 4 9 2 (2.5) 7 (8.6)
Class 5 6 1 (1.3) 5 (6.2)
(B) Management of complications
Antibiotics 42 14 (17.5) 28 (34.6) 0.014
Time to removal of surgical drain, median (days) [range] 6 5 [3-29] 6 [3-28] 0.942
Surgical drain present at discharge 108 52 (65.0) 56 (69.1) 0.576
Percutaneous drainage 23 10 (12.5) 13 (16.0) 0.520
Re-operation 12 2 (2.5) 10 (12.3) 0.017
Hospital LOS, median (days) [range] 9 8 [2-42] 9 [5-133] 0.013
ICU LOS, median (days) [range] 0 0 [0-11] 0 [0-120] 0.126
30-day readmission 35 15 (18.8) 20 (24.7) 0.361

LOS, length of stay; ICU, intensive care unit

Ann Hepatobiliary Pancreat Surg 2021;25:242-50 https://doi.org/10.14701/ahbps.2021.25.2.242
© 2021 Ann Hepatobiliary Pancreat Surg